CPAP trial honoured for excellence

The Sleep Apnea Cardiovascular Endpoints (SAVE) study has been honoured with an inaugural Excellence in Trial Statistics Award. Led by the Australasian Sleep Trials Network and Adelaide Institute for Sleep Health, the study as reported in the limbic, identified that CPAP does not reduce the risk of recurrent strokes and heart attacks for people with established cardiovascular ...

Already a member?

Login to keep reading.

© 2021 the limbic